Analysis of ion beam teletherapy patient-specific quality assurance

2019 ◽  
Vol 44 (1) ◽  
pp. 43-50 ◽  
Author(s):  
Xiaoli Liu ◽  
Yu Deng ◽  
Nicki Schlegel ◽  
Zhijie Huang ◽  
Michael F. Moyers
2015 ◽  
Vol 115 ◽  
pp. S438
Author(s):  
J. Horn ◽  
B. Ackermann ◽  
S. Brons ◽  
S. Lahrmann ◽  
C. Lampe ◽  
...  

2021 ◽  
Vol 9 ◽  
Author(s):  
L. Grevillot ◽  
D. J. Boersma ◽  
H. Fuchs ◽  
M. Bolsa-Ferruz ◽  
L. Scheuchenpflug ◽  
...  

Patient specific quality assurance can be improved using an independent dose calculation system. In addition, the implementation of such a system may support light ion beam therapy facilities in reducing the needs for beam time, by substituting some of the experimental patient-specific quality assurance procedures by independent dose calculation. The GATE-RTion-based IDEAL system for light ion beam therapy was developed for this purpose. It was built in a DICOM-in, DICOM-out fashion, for easy integration into a state-of-the-art technology-based workflow for scanned ion beam therapy. This article describes the IDEAL system, followed by its clinical implementation at MedAustron for proton and carbon ion beams. Medical physics acceptance and commissioning steps are presented together with key results: for 3D proton and carbon ion reference boxes, 97% of the points agreed within 5% from the measurements. Experimental validation of stopping powers using real pig samples were between 1.8% and 3.8% for soft tissues. Finally, five clinical cases are described, i.e. two proton and three carbon ion treatments. Dosimetric benchmarking against TPS calculations are presented and discussed in details. As expected, the IDEAL software evidenced limitations arising from the pencil beam algorithm available in the TPS for carbon ions, especially in the presence of air cavities. The IDEAL system was found to satisfy the clinical requirements for independent dose calculation of scanned ion beam delivery systems and is being clinically implemented at MedAustron. The open-source code as well as the documentation was released on the OpenGATE collaboration website, thus allowing for long term maintenance and future upgrades based on a more widespread utilization.


2020 ◽  
Vol 152 ◽  
pp. S748
Author(s):  
M. Schafasand ◽  
G. Kragl ◽  
J. Osorio ◽  
S. Vatnitsky ◽  
M. Stock ◽  
...  

2018 ◽  
Vol 56 ◽  
pp. 67-68 ◽  
Author(s):  
M. Zani ◽  
S. Calusi ◽  
R. Doro ◽  
N. Bellosi ◽  
M. Cassinelli ◽  
...  

2016 ◽  
Author(s):  
◽  
Jason Stanford

[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT REQUEST OF AUTHOR.] Advance treatment techniques, such as IMRT and dynamic conformal arc delivery, are novel radiation treatment procedures at the forefront of accurate and precise radiotherapy. However, the risk of suboptimal treatment resulting in injury is far greater with these techniques due to their complexity. An in vivo quality assurance system is the most appropriate validation of the delivered dose to the patient from these techniques. The intent of this research is to propose an in vivo dosimetry quality assurance procedure using radiochromic film. This research proved that radiochromic in vivo dosimetry is a viable method of detecting spatial patient specific errors in radiotherapy; however, the process is time consuming and not sensitive enough for dosimetric errors associated with weight change. Although time consuming, in vivo radiochromic dosimetry is an attractive alternative for small cancer centers and developing countries without the large startup capital to acquire the electronic portal imaging device necessary for EPID in vivo dosimetry.


Sign in / Sign up

Export Citation Format

Share Document